Changchun Institute of Biological Products Co., Ltd.
Establishment time : 1958
website : http://www.cibp.cric.cn/
Main Product : vaccines, biological products
Company Profile
Changchun Institute of Biological Products Co., Ltd. is a renowned biopharmaceutical company specializing in the research, development, and production of vaccines and biological products. Established in 1958, the company has grown to become a key player in the industry, with a strong presence in both the domestic and international markets. With a large company size and a reputation for high-quality products, CIBP is a leading producer of vaccines in China, known for its innovative research and commitment to public health.
Wuhan Institute of Biological Products Co., Ltd.
Establishment time : 1967
website : www.wibp.com.cn
Main Product : Biological products, vaccines
Company Profile
Wuhan Institute of Biological Products Co., Ltd. is a leading biopharmaceutical company in China, specializing in the research, development, and production of vaccines and biological products. Established in 1967, the company has a strong presence in the domestic market and has expanded its reach to international markets in Asia and Africa. With a medium-sized company size, Wuhan Institute of Biological Products Co., Ltd. faces competition from international pharmaceutical companies but maintains its competitive edge through its high-quality products and strong research capabilities. Visit their website at www.wibp.com.cn for more information.
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.
Establishment time : 1998
website : www.ty-pharm.com
Main Product : Heparin Sodium, Enoxaparin Sodium, Hyaluronic Acid, etc.
Company Profile
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is a pharmaceutical company founded in 1998, specializing in the production of bio-pharmaceutical products such as heparin sodium, enoxaparin sodium, and hyaluronic acid. With a large workforce of over 1000 employees, the company serves both domestic and international markets, including Europe, North America, and Asia. Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is known for its competitive position in the industry, offering high-quality products and innovative solutions to meet the needs of its customers.
Changchun Zhuoyi Biological Co., Ltd
Company Profile
Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.
Chengdu Institute of Biological Products Co., Ltd.
Establishment time : 1967
website : http://www.cdibp.com.cn/
Main Product : Vaccines, biological products
Company Profile
Chengdu Institute of Biological Products Co., Ltd. is a renowned company established in 1967, specializing in the production of vaccines and biological products. With a large company size, it serves both domestic and international markets, and is a leading player in the industry, known for its high-quality products. Visit their website for more information: http://www.cdibp.com.cn/
Liaoning Chengda Biotechnology Co., Ltd.
Establishment time : 2003
website : www.lncd.com.cn
Main Product : Probiotics, enzymes, feed additives
Company Profile
Liaoning Chengda Biotechnology Co., Ltd. is a leading biotechnology company specializing in the development and production of probiotics, enzymes, and feed additives. Established in 2003, the company has grown to become a key player in the industry, serving markets in China, Southeast Asia, and the Middle East. With a focus on quality and innovation, Chengda Biotechnology continues to compete strongly in the market, providing cutting-edge solutions for the agriculture and animal husbandry sectors.
June 24, 2024
